Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Sales | 175,049 | 2,154 | 2,153 | 2,155 | 2,094 |
| Gross Profit | 175,049 | 2,154 | 2,153 | 2,155 | 2,094 |
| Operating Expenses | 17,815 | 19,409 | 19,983 | 17,856 | 20,621 |
| Operating Income | 157,234 | -17,255 | -17,830 | -15,701 | -18,527 |
| Interest Expense | 38 | 71 | 59 | 65 | 82 |
| Other Income | 2,152 | -6,072 | -122 | -5,043 | -2,345 |
| Pre-tax Income | 159,348 | -23,398 | -18,011 | -20,809 | -20,954 |
| Net Income Continuous | 159,348 | -23,398 | -18,011 | -20,809 | -20,954 |
| Net Income | $159,348 | $-23,398 | $-18,011 | $-20,809 | $-20,954 |
| EPS Basic Total Ops | 1.44 | -0.21 | -0.15 | -0.21 | -0.24 |
| EPS Basic Continuous Ops | 1.44 | -0.21 | -0.15 | -0.21 | -0.24 |
| EPS Diluted Total Ops | 1.35 | -0.21 | -0.15 | -0.21 | -0.24 |
| EPS Diluted Continuous Ops | 1.37 | -0.21 | -0.15 | -0.21 | -0.24 |
| EBITDA(a) | $158,858 | $-15,917 | $-16,803 | $-14,573 | $-17,444 |